Skip to content
1887

Abstract

Fungal keratitis is a time-sensitive ocular infection that often requires a high index of suspicion followed by intensive medical/surgical interventions to achieve a successful clinical outcome. COVID-19 pandemic-related restrictions, necessitated the modification of conventional protocols and guidelines associated with the treatment of keratomycosis. We report four cases of atypical fungal keratitis with poorly differentiated clinical characteristics. The challenges faced during their management were (1) the dilemma of clinically differentiating fungal () and bacterial keratitis; (2) treatment of and keratitis with natamycin monotherapy; (3) mixed infection of and and continuing medications before rescraping the corneal ulcer against the recommended treatment guidelines; (4) phenotypic identification and differentiation among morphologically resembling fungi; and (5) decision making arising out of disparities between KOH and fungal culture results. Three patients responded well to conservative treatments. The fourth patient underwent therapeutic keratoplasty but was lost to follow-up due to travelrelated pandemic restrictions. This case series seeks to broaden the clinician’s knowledge of rare and emerging moulds as presumptive aetiologies of keratomycosis. It also intends to emphasize the significance of early microbiological investigations, (direct microscopy and culture), in resource-limited settings, for initiating empirical treatment for a better visual prognosis.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000570.v3
2023-08-08
2026-02-09

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/acmi/5/8/acmi000570.v3.html?itemId=/content/journal/acmi/10.1099/acmi.0.000570.v3&mimeType=html&fmt=ahah

References

  1. Chander J. Textbook of medical mycology. In Miscellaneous Mycoses, Related Topics, 3rd ed. New Delhi: Mehta Publishers; 2012 pp 400–409
    [Google Scholar]
  2. Ahmadikia K, Aghaei Gharehbolagh S, Fallah B, Naeimi Eshkaleti M, Malekifar P et al. Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020). Front Cell Infect Microbiol 2021; 11:698780 [View Article] [PubMed]
    [Google Scholar]
  3. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L et al. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci 2012; 53:1787–1791 [View Article] [PubMed]
    [Google Scholar]
  4. Farias R, Pinho L, Santos R. Epidemiological profile of infectious keratitis. Rev Bras Oftalmol 2017; 76:116–120 [View Article]
    [Google Scholar]
  5. Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog 2017; 104:97–109 [View Article] [PubMed]
    [Google Scholar]
  6. Vajpayee RB, Gupta SK, Bareja U, Kishore K. Ocular atopy and mycotic keratitis. Ann Ophthalmol 1990; 22:369–372 [PubMed]
    [Google Scholar]
  7. Prajna VN, Prajna L, Muthiah Srinivasan. Fungal keratitis: the Aravind experience. Indian J Ophthalmol 2017; 65:912 [View Article]
    [Google Scholar]
  8. Manikandan M. Epidemiology, rapid detection, and antifungal Susceptibilities of Fusarium and Aspergillus isolates from corneal Scrapings volume 2019, article ID. Biomed Res Int 2019; 6395840: [View Article]
    [Google Scholar]
  9. Tilak R, Singh A, Maurya OPS, Chandra A, Tilak V et al. Mycotic keratitis in India: a five-year retrospective study. J Infect Dev Ctries 2010; 4:171–174 [View Article] [PubMed]
    [Google Scholar]
  10. Satpathy G, Ahmed NH, Nayak N, Tandon R, Sharma N et al. Spectrum of mycotic keratitis in north India: Sixteen years study from a tertiary care ophthalmic centre. Journal of Infection and Public Health 2019; 12:367–371 [View Article]
    [Google Scholar]
  11. Suman S, Kumar A, Saxena I, Kumar M. Fungal Keratitis: Recent Advances in Diagnosis and Treatment. In Rodriguez-Garcia A, Hernandez-Camarena JC. eds Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment London: IntechOpen; 2021
    [Google Scholar]
  12. Ung L, Acharya NR, Agarwal T, Alfonso EC, Bagga B et al. Infectious corneal ulceration: a proposal for neglected tropical disease status. Bull World Health Organ 2019; 97:854–856 [View Article] [PubMed]
    [Google Scholar]
  13. Mahmoudi S, Masoomi A, Ahmadikia K, Tabatabaei SA, Soleimani M et al. Fungal keratitis: an overview of clinical and laboratory aspects. Mycoses 2018; 61:916–930 [View Article] [PubMed]
    [Google Scholar]
  14. Dan J, Zhou Q, Zhai H, Cheng J, Wan L et al. Clinical analysis of fungal keratitis in patients with and without diabetes. PLoS One 2018; 13:e0196741 [View Article] [PubMed]
    [Google Scholar]
  15. Jin X, Feng J, Sun N, Jin H, Wang J et al. A 5-year retrospective analysis of the risk factors, treatment, and prognosis of patients with fungal keratitis in Heilongjiang, China. Am J Ophthalmol 2022; 244:48–57 [View Article] [PubMed]
    [Google Scholar]
  16. Bharathi MJ, Ramakrishnan R, Meenakshi R, Mittal S, Shivakumar C et al. Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results. Br J Ophthalmol 2006; 90:1271–1276 [View Article] [PubMed]
    [Google Scholar]
  17. Bowling B. Kanski’s Clinical Ophthalmology. 8th ed W B Saunders; 2015
    [Google Scholar]
  18. Nulens E, Eggink C, Rijs AJMM, Wesseling P, Verweij PE. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol 2003; 41:2261–2264 [View Article] [PubMed]
    [Google Scholar]
  19. Fadzillah M-T, Ishak S-R, Ibrahim M. Refractory Scedosporium apiospermum keratitis successfully treated with combination of amphotericin B and voriconazole. Case Rep Ophthalmol Med 2013; 2013:413953 [View Article] [PubMed]
    [Google Scholar]
  20. Walsh TJ, Hayden RT, Larone DH. Larone’s medically important fungi. In Larone’s Medically Important Fungi- A Guide to Identification, 6th ed. Washington, DC, USA: ASM Press; 2018
    [Google Scholar]
  21. Hoenigl M, Salmanton-García J, Walsh TJ, Nucci M, Neoh CF et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis 2021; 21:e246–e257 [View Article] [PubMed]
    [Google Scholar]
  22. Prajna NV, Krishnan T, Rajaraman R, Patel S, Srinivasan M et al. Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial. JAMA Ophthalmol 2016; 134:1365–1372 [View Article] [PubMed]
    [Google Scholar]
  23. Yildirim N, Oz Y, Aydin Yaz Y. Scedosporium apiospermum keratitis treated with voriconazole. Eur Eye Res 2022; 2:189–193 [View Article]
    [Google Scholar]
  24. Ramakrishnan S, Mandlik K, Sathe TS, Gubert J, Krishnan T et al. Ocular infections caused by Scedosporium apiospermum: a case series. Indian J Ophthalmol 2018; 66:137–140 [View Article] [PubMed]
    [Google Scholar]
  25. Rathi HS, Venugopal A, Rengappa R, Ravindran M. Scedosporium keratitis: an experience from a tertiary eye hospital in South India. Cornea 2016; 35:1575–1577 [View Article] [PubMed]
    [Google Scholar]
  26. Ghosh AK, Gupta A, Rudramurthy SM, Paul S, Hallur VK et al. Fungal keratitis in North India: spectrum of agents, risk factors and treatment. Mycopathologia 2016; 181:843–850 [View Article] [PubMed]
    [Google Scholar]
  27. Chander J, Singla N, Agnihotri N, Arya S, Deep A. Keratomycosis in and around Chandigarh: a five-year study from a north Indian tertiary care hospital. Indian J Pathol Microbiol 2008; 51:304 [View Article]
    [Google Scholar]
  28. Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect 2013; 19:210–220 [View Article] [PubMed]
    [Google Scholar]
  29. Sengupta J, Khetan A, Saha S, Banerjee D, Gangopadhyay N et al. Candida keratitis: emerging problem in India. Cornea 2012; 31:371–375 [View Article] [PubMed]
    [Google Scholar]
  30. Tuft SJ, Tullo AB. Fungal keratitis in the United Kingdom 2003-2005. Eye 2009; 23:1308–1313 [View Article] [PubMed]
    [Google Scholar]
  31. Chen WL, Tsai YY, Lin JM, Chiang CC. Unilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis: case report and review of the literature. Cornea 2009; 28:105–107 [View Article] [PubMed]
    [Google Scholar]
  32. Dimitri T A, Joelle H, Scott D. B, Pushpanjali G, Pavan-Langston D. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases pp 1508–1522
    [Google Scholar]
  33. Augustin JB, Variamkandi S. Clinical and etiological profile of mycotic keratitis from a tertiary care centre in South India. J Evolution Med Dent Sci 2021; 10:2001–2006 [View Article]
    [Google Scholar]
  34. Panda A, Das H, Deb M, Khanal B, Kumar S. Aureobasidium pullulans keratitis. Clin Exp Ophthalmol 2006; 34:260–264 [View Article] [PubMed]
    [Google Scholar]
  35. Chowdhary A, Perfect J, de Hoog GS. Black molds and melanized yeasts pathogenic to humans. Cold Spring Harb Perspect Med 2014; 5:a019570 [View Article] [PubMed]
    [Google Scholar]
  36. Perdomo H, Cano J, Gené J, García D, Hernández M et al. Polyphasic analysis of Purpureocillium lilacinum isolates from different origins and proposal of the new species Purpureocillium lavendulum . Mycologia 2013; 105:151–161 [View Article] [PubMed]
    [Google Scholar]
  37. Yuan X, Wilhelmus KR, Matoba AY, Alexandrakis G, Miller D et al. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol 2009; 147:691–696 [View Article] [PubMed]
    [Google Scholar]
  38. Mikami Y, Fukushima K, Arai T, Abe F, Shibuya H et al. Leucinostatins, peptide mycotoxins produced by Paecilomyces lilacinus and their possible roles in fungal infection. Zentralbl Bakteriol Mikrobiol Hyg A 1984; 257:275–283 [PubMed]
    [Google Scholar]
  39. Leal SM, Pearlman E. The role of cytokines and pathogen recognition molecules in fungal keratitis - Insights from human disease and animal models. Cytokine 2012; 58:107–111 [View Article] [PubMed]
    [Google Scholar]
  40. Chen Y-T, Yeh L-K, Ma DHK, Lin H-C, Sun C-C et al. Paecilomyces/Purpureocillium keratitis: a consecutive study with a case series and literature review. Med Mycol 2020; 58:293–299 [View Article]
    [Google Scholar]
  41. Hirst LW, Choong K, Playford EG. Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance. Cornea 2014; 33:1031–1037 [View Article] [PubMed]
    [Google Scholar]
  42. Ali TK, Amescua G, Miller D, Suh LH, Delmonte DW et al. Contact-lens-associated Purpureocillium Keratitis: risk factors, microbiologic characteristics, clinical course, and outcomes. Semin Ophthalmol 2017; 32:157–162 [View Article] [PubMed]
    [Google Scholar]
  43. Todokoro D, Yamada N, Fukuchi M, Kishi S. Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers. Int Ophthalmol 2014; 34:1159–1163 [View Article]
    [Google Scholar]
  44. Arnoldner MA, Kheirkhah A, Jakobiec FA, Durand ML, Hamrah P. Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole. Cornea 2014; 33:747–749 [View Article] [PubMed]
    [Google Scholar]
  45. Ford JG, Agee S, Greenhaw ST. Successful medical treatment of a case of Paecilomyces lilacinus keratitis. Cornea 2008; 27:1077–1079 [View Article] [PubMed]
    [Google Scholar]
  46. Wu P-C, Lai C-H, Tan H-Y, Ma DHK, Hsiao C-H. The successful medical treatment of a case of Paecilomyces lilacinus keratitis. Cornea 2010; 29:357–358 [View Article] [PubMed]
    [Google Scholar]
  47. Butt GF, Recchioni A, Moussa G, Hodson J, Wallace GR et al. The impact of the COVID-19 pandemic on microbial keratitis presentation patterns. PLoS One 2021; 16:e0256240 [View Article] [PubMed]
    [Google Scholar]
  48. Tawde Y, Singh S, Das S, Rudramurthy SM, Kaur H et al. Clinical and mycological profile of fungal keratitis from North and North-East India. Indian J Ophthalmol 2022; 70:1990–1996 [View Article] [PubMed]
    [Google Scholar]
  49. Thomas M, Varghese A, Rajan R, Ka S, Kurian P. Checklist of microfungi in Kerala, India. Asian Jr of Microbiol Biotech Env Sc 2011; 13:651–665
    [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000570.v3
Loading
/content/journal/acmi/10.1099/acmi.0.000570.v3
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error